Spectrum Pharmaceuticals Inc. (SPPI)

19.25
0.18 0.93
NASDAQ : Health Technology
Prev Close 19.43
Open 19.50
Day Low/High 19.14 / 19.73
52 Wk Low/High 5.47 / 23.50
Volume 122.14K
Avg Volume 1.58M
Exchange NASDAQ
Shares Outstanding 104.06M
Market Cap 2.10B
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Company Profile For SPECTRUM PHARMACEUTICALS

null

Spectrum Pharmaceuticals To Present Corporate Update At The H.C. Wainwright Global Life Sciences Conference On April 10th

Spectrum Pharmaceuticals To Present Corporate Update At The H.C. Wainwright Global Life Sciences Conference On April 10th

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the...

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACSF, ATRC, BKE, CRSP, HALO Downgrades: GIFI, GTE, MGI, NNI, RBBN, SHAK, SPPI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Spectrum Pharmaceuticals To Present Corporate Update At The Cowen And Company 38th Annual Health Care Conference On March 13th

Spectrum Pharmaceuticals To Present Corporate Update At The Cowen And Company 38th Annual Health Care Conference On March 13th

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the...

Spectrum Pharmaceuticals Reports Fourth Quarter 2017 And Full Year 2017 Financial Results And Pipeline Update

Spectrum Pharmaceuticals Reports Fourth Quarter 2017 And Full Year 2017 Financial Results And Pipeline Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today financial results...

Spectrum Pharmaceuticals Announces Appointment Of William L. Ashton To Its Board Of Directors

Spectrum Pharmaceuticals Announces Appointment Of William L. Ashton To Its Board Of Directors

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced the appointment of...

Spectrum Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a...

Spectrum Pharmaceuticals To Present Corporate Update At The 2018 RBC Capital Markets Global Healthcare Conference On February 22nd

Spectrum Pharmaceuticals To Present Corporate Update At The 2018 RBC Capital Markets Global Healthcare Conference On February 22nd

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the...

Spectrum Pharmaceuticals Announces ROLONTIS™ (eflapegrastim) Met The Primary Endpoint In The Phase 3 ADVANCE Study

Spectrum Pharmaceuticals Announces ROLONTIS™ (eflapegrastim) Met The Primary Endpoint In The Phase 3 ADVANCE Study

Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the first Phase...

First Week of March 16th Options Trading For Spectrum Pharmaceuticals (SPPI)

First Week of March 16th Options Trading For Spectrum Pharmaceuticals (SPPI)

Investors in Spectrum Pharmaceuticals Inc saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SPPI options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

SPPI December 21st Options Begin Trading

SPPI December 21st Options Begin Trading

Investors in Spectrum Pharmaceuticals Inc saw new options begin trading today, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 332 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Spectrum Pharmaceuticals To Present Corporate Update At The Noble Capital Markets' Fourteenth Annual Investor Conference

Spectrum Pharmaceuticals To Present Corporate Update At The Noble Capital Markets' Fourteenth Annual Investor Conference

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the...

Spectrum Pharmaceuticals Announces Leadership Changes

Spectrum Pharmaceuticals Announces Leadership Changes

Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that its Board of...

Spectrum Pharmaceuticals Highlights Two Oral Presentations On FOLOTYN® (pralatrexate Injection) at The 59th Annual Meeting Of The American Society Of Hematology (ASH)

Spectrum Pharmaceuticals Highlights Two Oral Presentations On FOLOTYN® (pralatrexate Injection) at The 59th Annual Meeting Of The American Society Of Hematology (ASH)

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced two oral presentations of data...

Spectrum Pharmaceuticals Highlights 15 Abstracts At The 59th Annual Meeting Of The American Society Of Hematology (ASH) In Atlanta, Georgia, December 9-12, 2017

Spectrum Pharmaceuticals Highlights 15 Abstracts At The 59th Annual Meeting Of The American Society Of Hematology (ASH) In Atlanta, Georgia, December 9-12, 2017

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced key presentations of...

Spectrum Pharmaceuticals Stock Sees Short Interest Move 11.2% Higher

Spectrum Pharmaceuticals Stock Sees Short Interest Move 11.2% Higher

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 805,681 share increase in total short interest for Spectrum Pharmaceuticals Inc , to 8,021,402, an increase of 11.17% since 10/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Spectrum Pharmaceuticals To Present Corporate Update At The Jefferies 2017 London Healthcare Conference On November 15th

Spectrum Pharmaceuticals To Present Corporate Update At The Jefferies 2017 London Healthcare Conference On November 15th

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an...

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

The Menlo Park, Calif.-based firm had a third-quarter net loss of $22 million, compared with $17.5 million in the year-ago period. Product, service and other revenue rose 9% year-over-year to $23.5 million.

Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results And Pipeline Update

Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results And Pipeline Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced today financial results for...

Spectrum Pharmaceuticals Announces Initiation Of A Multicenter Phase 2 Trial Of Poziotinib In Non-Small Cell Lung Cancer (NSCLC) Patients With Exon 20 Insertion Mutation In EGFR Or HER2

Spectrum Pharmaceuticals Announces Initiation Of A Multicenter Phase 2 Trial Of Poziotinib In Non-Small Cell Lung Cancer (NSCLC) Patients With Exon 20 Insertion Mutation In EGFR Or HER2

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today the initiation of a...

TheStreet Quant Rating: D+ (Sell)